Axsome Therapeutics annual gross margin
2022
2023
2024
2025
Axsome Therapeutics Gross Margin Growth & History (AXSM)
Axsome Therapeutics's gross margin was 92.56% for fiscal 2025.
View full Axsome Therapeutics company overviewAxsome Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 92.56% | +1.20 pp |
| 2024 | 2024-12-31 | 91.37% | +1.00 pp |
| 2023 | 2023-12-31 | 90.37% | +0.76 pp |
| 2022 | 2022-12-31 | 89.61% | — |
Axsome Therapeutics quarterly gross margin
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 93.79% | +2.75 pp |
| Q1 2026 | 2026-03-31 | 92.30% | +0.36 pp |
| Q4 2025 | 2025-12-31 | 93.71% | +2.56 pp |
| Q3 2025 | 2025-09-30 | 93.03% | +1.09 pp |
| Q2 2025 | 2025-06-30 | 91.04% | +0.28 pp |
| Q1 2025 | 2025-03-31 | 91.94% | +0.34 pp |
| Q4 2024 | 2024-12-31 | 91.15% | +1.46 pp |
| Q3 2024 | 2024-09-30 | 91.95% | +3.25 pp |
| Q2 2024 | 2024-06-30 | 90.76% | +0.61 pp |
| Q1 2024 | 2024-03-31 | 91.60% | −0.41 pp |
| Q4 2023 | 2023-12-31 | 89.69% | — |
| Q3 2023 | 2023-09-30 | 88.70% | −0.02 pp |
| Q2 2023 | 2023-06-30 | 90.15% | +1.49 pp |
| Q1 2023 | 2023-03-31 | 92.01% | — |
| Q3 2022 | 2022-09-30 | 88.72% | — |
| Q2 2022 | 2022-06-30 | 88.66% | — |
Axsome Therapeutics gross margin trends
Between the periods ended 2022-12-31 and 2025-12-31, Axsome Therapeutics's gross margin increased from 89.61% to 92.56%, a change of +2.96 percentage points. The latest reported quarter, Q2 2026, shows 93.79%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Axsome Therapeutics source filings ↗